FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

CNC

Centene CorporationNYSE · Managed Health Care · Health Care
Previous close
68.45
Change
−0.17 / −0.25%
FinDog View
Neutral
52-Week Range ?
31.63 – 72.50
P/E (TTM) ?
—
Forward P/E ?
13.0
Based on consensus earnings for the next 12 months
Market Cap
$33.6B
1M
+10.19%
S&P 500 −0.91% over same period
Volume / Avg Volume
4.8M / 5.4M
0.89× average
Latest earnings analysisFY2026 Q2Reported 2026-07-28

Centene Q2 2026: EPS $2.19, HBR improves to 89.6%, guidance floors raised

Centene swung from a $253 million loss a year ago to $1.09 billion of net income this quarter, cut its health benefits ratio to 89.6% and raised its full-year earnings floors — a better quarter than the headline EPS suggests. The catch: membership fell to 25.9 million, and the guidance implies a second-half loss.

Read the full analysis →
Revenue$44.38BYoY −9.00%
EPS (non-GAAP)$2.51Beatest. $1.10
Next-quarter revenue guidance$195.50B ±1.02%YoY +340.60%
Next-day move−3.27%

Price History

Closing price · USD1M6M1Y5Y
606570752026-092026-102026-102026-102026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 8.81M6M1Y5Y
8.28.48.68.89.09.22025-102025-112025-112025-112025-11

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2027-02-04
in 95 days · After hours
Consensus EPS
$-1.10
Last quarter EPS $2.51
Avg. next-day move over the last 5 reports
±12.0%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
A 5-year P/E range needs a longer earnings record; not yet comparable
Last 4 quarters: $59.0M in buybacks + $0 in dividends, 0.18% of market cap combined
P/E (TTM)
—
P/B
1.5
P/S
0.2
PEG
—
Earnings Reaction
Over the last 5 reports, the stock moved ±12.0% on average on the first trading day after, rising 0 times
Most recent −3.27%
Volatility & Correlation
1-year beta 0.32 · Correlation with S&P 500 0.09Low beta
Annualized volatility 46% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $6.9MNet selling $6.9M
  • 08-26KOSTER CHRISTOPHERSecretary & General CounselSell$3.8M56,500 shares · Avg price 66.90
  • 08-18KOSTER CHRISTOPHERSecretary & General CounselSell$3.1M47,603 shares · Avg price 65.36
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q345.11+0.5%98.5%-0.31-0.07-3.86-0.14
FY2026 Q244.38+4.5%98.4%1.201.093.422.19
FY2026 Q144.66+5.1%98.4%1.861.544.173.11
FY2025 Q444.73+23.2%98.5%-1.75-1.100.22-2.15
FY2025 Q344.90+21.7%98.6%-6.95-6.631.15-13.50
FY2025 Q242.47+18.1%98.5%-0.46-0.251.58-0.51
FY2025 Q142.49+16.9%98.4%1.531.311.382.63
FY2024 Q436.30+2.7%98.1%0.180.28-0.740.63
FY2024 Q336.90+5.5%98.1%0.670.71-1.131.36
FY2024 Q235.97+3.3%98.1%1.231.151.992.16
FY2024 Q136.34+4.0%98.2%1.111.16-0.612.16
FY2023 Q435.34+5.3%97.3%-0.190.05-0.010.12

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView